NTUS - Natus Medical to be acquired by Archimed Group for $33.50/share in cash or $1.2B

Natus Medical (NASDAQ:NTUS) to be acquired by an affiliate of ArchiMed, an investment firm focused exclusively on the healthcare industry for ~$1.2B. Shareholders will receive $33.50 in cash for each share of Natus (NTUS) common stock, representing a 29% premium to the closing price on April 14, 2022. “The sale of Natus to ArchiMed will provide our shareholders with immediate and substantial cash value, as well as a compelling premium, and the Board has unanimously agreed that this transaction is in the best interests of our shareholders,” said Joshua H. Levine, Chairman of Natus. Upon completion of the transaction in 3Q22, the company will become a private company and shares will no longer be listed on any public market. The company have the right to terminate the merger agreement with ArchiMed to enter into a superior proposal subject to the terms and conditions of such agreement. The company sees Q1

For further details see:

Natus Medical to be acquired by Archimed Group for $33.50/share in cash or $1.2B